Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 9/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.56 |
| ▸ | NPC1 | O15118 | 4/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | CA1 | P00915 | 2/20 | 0.55 |
| ▸ | CA2 | P00918 | 2/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.54 |
| ▸ | ESR1 | P03372 | 1/20 | 0.54 |
| ▸ | CA7 | P43166 | 1/20 | 0.54 |
| ▸ | CA9 | Q16790 | 1/20 | 0.54 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | CASP3 | P42574 | 1/20 | 0.54 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10813076 | 0.94 | SMN1; SMN2 (0.62) | HPGDRECQLRAB9ASMN1; SMN2NPC1 | |
| SCHEMBL7379234 | 0.84 | RAB9A (0.53) | HPGDRECQLRAB9ASMN1; SMN2NPC1 | |
| SCHEMBL10664774 | 0.83 | MAPT (0.59) | HPGDRECQLRAB9ASMN1; SMN2NPC1 | |
| SCHEMBL10669998 | 0.83 | MAPT (0.59) | HPGDRECQLRAB9ASMN1; SMN2NPC1 | |
| SCHEMBL10670435 | 0.83 | MAPT (0.59) | HPGDRECQLRAB9ASMN1; SMN2NPC1 | |
| SCHEMBL10666583 | 0.80 | ABCB11 (0.60) | HPGDRECQLRAB9ASMN1; SMN2NPC1 | |
| SCHEMBL12124929 | 0.79 | RAB9A (0.69) | HPGDRECQLRAB9ASMN1; SMN2NPC1 | |
| SCHEMBL87450 | 0.78 | CA1 (0.83) | HPGDRECQLRAB9ASMN1; SMN2NPC1 | |
| SCHEMBL10670386 | 0.78 | ABCB11 (0.45) | HPGDRECQLRAB9ASMN1; SMN2NPC1 | |
| SCHEMBL3233695 | 0.78 | HPGD (0.65) | HPGDRECQLRAB9ASMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140255324-A1 | CRYSTALLINE FORM OF A TRIAZINE DERIVATIVE AND THE PROCEDURE FOR ITS PRODUCTION | 3V SIGMA S.P.A. (IT) | 2014-09-11 | — | — | US | disclosed |
| EP-2774921-A1 | Crystalline form of a triazine derivative, the procedure for its production and cosmetic formulations thereof | 3V SIGMA S.p.A (IT) | 2014-09-10 | — | — | EP | disclosed |
| US-4724137-A | s-Triazine derivatives and their use as sun screen agents | BASF AKTIENGESELLSCHAFT (DE) | 1988-02-09 | — | — | US | disclosed |
| US-4617390-A | SUNSCREEN AGENTS | BASF AKTIENGESELLSCHAFT (DE) | 1986-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140255324-A1 | CRYSTALLINE FORM OF A TRIAZINE DERIVATIVE AND THE PROCEDURE FOR ITS PRODUCTION | CRYZ, TBCD, TBCA | HPGD 1335/4885RECQL 1651/4885RAB9A 3103/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.